217 related articles for article (PubMed ID: 10675356)
1. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation.
Tanemura M; Yin D; Chong AS; Galili U
J Clin Invest; 2000 Feb; 105(3):301-10. PubMed ID: 10675356
[TBL] [Abstract][Full Text] [Related]
2. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
3. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
Galili U
Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.
Mohiuddin MM; Ogawa H; Yin DP; Shen J; Galili U
Transplantation; 2003 Feb; 75(3):258-62. PubMed ID: 12589143
[TBL] [Abstract][Full Text] [Related]
5. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
6. Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene.
Ogawa H; Yin DP; Galili U
Gene Ther; 2004 Feb; 11(3):292-301. PubMed ID: 14737089
[TBL] [Abstract][Full Text] [Related]
7. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance.
Ogawa H; Mohiuddin MM; Yin DP; Shen J; Chong AS; Galili U
Transplantation; 2004 Feb; 77(3):366-73. PubMed ID: 14966409
[TBL] [Abstract][Full Text] [Related]
8. Anti-gal A/B, a novel anti-blood group antibody identified in recipients of abo-incompatible kidney allografts.
Galili U; Ishida H; Tanabe K; Toma H
Transplantation; 2002 Dec; 74(11):1574-80. PubMed ID: 12490791
[TBL] [Abstract][Full Text] [Related]
9. Immune response, accommodation, and tolerance to transplantation carbohydrate antigens.
Galili U
Transplantation; 2004 Oct; 78(8):1093-8. PubMed ID: 15502700
[TBL] [Abstract][Full Text] [Related]
10. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines.
Galili U; Wigglesworth K; Abdel-Motal UM
J Immunol; 2007 Apr; 178(7):4676-87. PubMed ID: 17372027
[TBL] [Abstract][Full Text] [Related]
12. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
13. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells.
Mohiuddin MM; Ogawa H; Yin DP; Galili U
Blood; 2003 Jul; 102(1):229-36. PubMed ID: 12649147
[TBL] [Abstract][Full Text] [Related]
14. Elimination of anti-Gal B cells by alpha-Gal ricin1.
Tanemura M; Ogawa H; Yin DP; Chen ZC; DiSesa VJ; Galili U
Transplantation; 2002 Jun; 73(12):1859-68. PubMed ID: 12131678
[TBL] [Abstract][Full Text] [Related]
15. Potential implications of ABO blood group for vascular rejection in pig to human kidney xenotransplantation.
Oostingh GJ; Davies HF; Arch BN; Bradley JA; Taylor CJ
Xenotransplantation; 2003 May; 10(3):278-84. PubMed ID: 12694548
[TBL] [Abstract][Full Text] [Related]
16. Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection.
Galili U; LaTemple DC; Walgenbach AW; Stone KR
Transplantation; 1997 Mar; 63(5):646-51. PubMed ID: 9075832
[TBL] [Abstract][Full Text] [Related]
17. The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation.
Galili U
Biochimie; 2001 Jul; 83(7):557-63. PubMed ID: 11522383
[TBL] [Abstract][Full Text] [Related]
18. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters.
Galili U; Tibell A; Samuelsson B; Rydberg L; Groth CG
Transplantation; 1995 Jun; 59(11):1549-56. PubMed ID: 7539957
[TBL] [Abstract][Full Text] [Related]
19. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
Galili U
Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
[TBL] [Abstract][Full Text] [Related]
20. Antibody production and tolerance to the α-gal epitope as models for understanding and preventing the immune response to incompatible ABO carbohydrate antigens and for α-gal therapies.
Galili U
Front Mol Biosci; 2023; 10():1209974. PubMed ID: 37449060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
